A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2006
12/14/2006	US20060280820 Use of an extract of Aloysia/Verbena/Lippia triphylla/citriodora for the treatment of chronic and/or inflammatory diseases
12/14/2006	US20060280745 Prion inhibition
12/14/2006	US20060280743 Immunoglobulin for treatment of alzheimer's diseases
12/14/2006	US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis
12/14/2006	US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns
12/14/2006	CA2620986A1 3 -aryloxy- 8 -aza-bicyclo [3.2.1.] oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/14/2006	CA2611724A1 Stabilized milnacipran formulation
12/14/2006	CA2611713A1 Treatment of sleep-wake disorders
12/14/2006	CA2611609A1 Ampa receptor potentiators
12/14/2006	CA2611430A1 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/14/2006	CA2611401A1 Oxindoles as kinase inhibitors
12/14/2006	CA2610986A1 Agent for treating and/or preventing neuropathic pain
12/14/2006	CA2610838A1 Novel salts of conjugated psychotropic drugs and processes of preparing same
12/14/2006	CA2610802A1 Use op brivaracetam for the treatment of diseases characterized by progressive myoclonic epilepsy
12/14/2006	CA2610771A1 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	CA2610655A1 Cyclobutyl amine derivatives
12/14/2006	CA2610400A1 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006	CA2609969A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/13/2006	EP1731913A2 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
12/13/2006	EP1731529A1 Calcium ion leakage inhibitors
12/13/2006	EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006	EP1731507A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
12/13/2006	EP1731502A1 Novel crystal of triterpene derivative
12/13/2006	EP1731168A1 Antibody drug
12/13/2006	EP1731159A1 Method of preventing nodavirus infection and therapeutic method
12/13/2006	EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006	EP1731152A2 Sustained analgesia achieved with transdermal delivery of buprenorphine
12/13/2006	EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
12/13/2006	EP1731149A1 Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
12/13/2006	EP1731131A1 Hgf production accelerator containing heparin-like oligosaccharide
12/13/2006	EP1730144A1 Substituted 1,4,8-triazaspiro¬4.5\|decan-2-one compounds
12/13/2006	EP1730137A1 Heterocyclic cgrp antagonists for the treatment of migraine
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
12/13/2006	EP1729772A2 Heteroaryl piperidine glycine transporter inhibitors
12/13/2006	EP1729771A1 Pyridyl derivatives and their use as mglu5 receptor antagonists
12/13/2006	EP1729761A1 Cadasil treatment with cholinesterase inhibitors
12/13/2006	EP1729759A1 Salvinorin derivatives and uses thereof
12/13/2006	EP1729756A2 Novel pharmaceutical compositions
12/13/2006	EP1729755A1 Methods of treatment of amyloidosis using aspartyl-protease inihibitors
12/13/2006	EP1729751A1 Use of an nk3 antagonist for the treatment of bipolar disorders
12/13/2006	EP1729749A2 Use of renin inhibitors in therapy
12/13/2006	EP1729748A1 Microemulsion preconcentrate comprising a renin inhibitor
12/13/2006	EP1729747A2 Thiol reactive agents as a therapeutic modality
12/13/2006	EP1729737A1 Disintegrating tablets comprising licarbazepine
12/13/2006	EP1596856B1 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
12/13/2006	EP1501523A4 Carbon monoxide as a biomarker and therapeutic agent
12/13/2006	EP1478382B1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
12/13/2006	EP1446127B1 Triazepine derivatives as neurotrophic agents
12/13/2006	EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006	EP1420788B1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
12/13/2006	EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/13/2006	EP1261712B1 Proteins named fctrx and nucleic acids encoding same
12/13/2006	EP1206554B1 Activatable recombinant neurotoxins
12/13/2006	EP1179067B1 Neuroprotective properties of gdf-15, a member of the tgf-beta superfamily
12/13/2006	EP1123392B1 Prv-1 gene and the use thereof
12/13/2006	EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006	CN1878773A Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
12/13/2006	CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives
12/13/2006	CN1878764A Beta-lactams for treatment of cns disorders
12/13/2006	CN1878762A Morpholine derivatives as norepinephrine reuptake inhibitors
12/13/2006	CN1878756A Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006	CN1878546A Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders
12/13/2006	CN1876683A Human antibodies that bind human TNFalpha
12/13/2006	CN1876682A Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method
12/13/2006	CN1876653A Zolpidem hemitartrate
12/13/2006	CN1876652A Zolpidem hemitartrate
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1876634A Sinomenine structure-modified compound and its preparation method
12/13/2006	CN1876175A Neurotrophic factor slow release nanometer formulation and its preparation method and uses
12/13/2006	CN1876153A A preparation method of medicine for treating hemiparalysis caused by apoplexy
12/13/2006	CN1876152A A medicine for treating nervous deafness and preparation process thereof
12/13/2006	CN1876147A A novel 'Tian Meng' soft capsule and preparation method thereof
12/13/2006	CN1876121A A medicinal wine capable of treating multiple diseases
12/13/2006	CN1876094A A drug-breaking medicine and preparation method thereof
12/13/2006	CN1876087A A medicament for treating tension headache and preparation method thereof
12/13/2006	CN1876083A A blood circulation-invigorating tendon-strengthening capsule and preparation process thereof
12/13/2006	CN1876080A Bolus for treating collateral and gynecological disease
12/13/2006	CN1876056A A medicine for treating neurasthenia and preparation process thereof
12/13/2006	CN1876034A An externally applied analgetic and preparation method thereof
12/13/2006	CN1876026A A medicine for treating early-stage senile dementia and preparation process thereof
12/13/2006	CN1876004A A medicament for treating cerebrovascular disease
12/13/2006	CN1876003A Preparation method of effective parts of cynanchum bunaei and its use in treatment of insomina
12/13/2006	CN1875997A Application of sundew in pharmaceutical preparation
12/13/2006	CN1875994A Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/13/2006	CN1875975A Application of ocotillol type ginsenoside and its glucoside
12/13/2006	CN1875968A Application of anisodamine in preparation of smoking-stopping medicament
12/13/2006	CN1875954A An oral administered medicine for treating depression-Jin Yu Kang
12/13/2006	CN1875949A Soft gastrodine capsule and preparation method thereof
12/13/2006	CN1289509C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, and pharmaceutical compositions containing same
12/13/2006	CN1289508C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same
12/13/2006	CN1289499C Pirazino (aza) indole derivatives
12/13/2006	CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006	CN1289496C Process for producing novel paroxetine hydrochloride anhydrate
12/13/2006	CN1289495C New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
12/13/2006	CN1289479C 5-cyclo indole compounds as 5-HT receptor ligands
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders

1 ... 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 ... 1833